Pfizer Animal Genetics is expanding its presence in the UK with the appointment of a dedicated team.

The company says it will use state-of-the-art genetic technology to improve the health, welfare and productivity of animals, and that the move comes at an exciting time for genetic research, as complete sequencing of the bovine genome has resulted in explosive growth of the possibilities.

As well as being able to provide tests addressing parentage (SireTRACE) and traceability (SureTRAK), Pfizer Animal Genetics can also help farmers identify the genetic potential that each animal has to produce tender, well marbled meat and to perform at optimal feed conversion efficiency (GeneSTAR) - vital management information that can improve profitability and enable effective decision making in long term breeding plans.

The company promises there is more to come, with exponential growth in the identification of genetic markers, which will allow the imminent introduction of new tests set to provide much more detailed predictive information about individual animals - all available virtually from birth onwards.

Richard Chew (above right) is Customer Service Manager and the first port of call for anyone with questions about pricing & submission forms, samples and reports.  Richard grew up in rural Lancashire and went on to study at the University of Bristol. Since graduation his career has taken him through a variety of scientific and customer facing roles. He has worked for Pfizer Animal Health for six years in the clinical development of vaccines and pharmaceuticals for livestock and is looking forward to the new challenges of the genetics business. Richard is based in Pfizer's Surrey office and can be reached on 08345 3037398 or PfizerAnimalGenetics-EU@pfizer.com.

Mike Marron and Peter Quigley are Dairy Sales Manager and Beef and Sheep Sales Manager respectively and will be the contact points for breed associations, organisations and individuals who want to discuss how genetic assessment and identification can help assure the quality of a breed or herd. Mike has an honours degree in biological and biochemical science and a decade of experience in the animal health industry, with special interests in fertility and calf management. Peter also comes from the animal health industry and is looking forward to continuing the company's work with the Aberdeen Angus Society as well as developing programmes for other beef breed societies.

Mike or Peter will be in attendance at various agricultural shows across the UK including Agrilive, the South West Dairy Show, Surecalf, Agriscot, Thainstone Christmas Classic, the Welsh Winter Fair, The Great Yorkshire Show and the Northern Ireland Winter Fair, where they will be explaining how genetic testing can make a contribution towards improving the brand value of a breed and shortening the time frame to allow better management decisions to be made.

Dr Gary Evans is Technical Services Manager and will be providing detailed advice on how to improve pedigree herd books, the interpretation of results of genetic testing and detection of certain genetic diseases. Gary is a geneticist with fourteen years experience in the application of genomics to livestock and joins Pfizer Animal Genetics from PIC/Genus.

The Department for Environment, Food and Rural Affairs (Defra) has today released details of the strategy for rolling out vaccination across England.

Under EU law, vaccination can only be carried out in a Protection Zone. As vaccine starts to be delivered by Intervet, vaccination will, therefore, commence in the Protection Zone only. Once vaccination is progressing across the Protection Zone, the intention is to extend or modify the Zone county by county, in order to permit further vaccination. The strategy has been developed and agreed with a Core Group of industry stakeholders. It is designed to be flexible, taking into account the changing nature of the disease, such as moving zones, the varying levels of disease risk in the zones and the availability of vaccine.

More details of the vaccination strategy, alongside indicative prices for the vaccine, can be found on the Defra website: http://www.defra.gov.uk/animalh/diseases/notifiable/bluetongue/control/vaccination-rolloutplan.htm

Dechra Veterinary Products has launched Ketodale, an anti-inflammatory injection for cattle, horses and swine.

Ketodale contains the non-steroidal anti-inflammatory drug ketoprofen 100mg/ml.  It is indicated for use in cattle and swine for diseases associated with inflammation, pain or fever. In cattle these include respiratory diseases, mastitis, osteoarticular and muscular-skeletal disorders, such as lameness and arthritis, and to ease pain post parturition. Ketodale can be used to treat swine suffering from Mastitis Metritis Agalactia (MMA) Syndrome and respiratory tract infections. 

In horses, Ketodale is indicated for diseases affecting the osteoarticular and muscular-skeletal system associated with pain and inflammation. These include naviculitis, arthritis and laminitis. It can also be used for post-surgical inflammation and symptomatic therapy of colic and fever.

Ketodale is available in 50ml and 100ml vials.

To coincide with the product's launch, Dechra is carrying out a direct marketing campaign. Practices can take advantage of a special launch offer where they can purchase four vials and get a fifth free. The offer is available for a limited period only. 

To find out more about Ketodale, call Dechra on 01743 441 632 or visiting www.dechra.com

Novartis Animal Health UK has announced that it is committed to maintaining a reliable supply of Bovidec BVD virus vaccine throughout the coming season.

The announcement comes following concerns surrounding the availability of BVD vaccines. Novartis Brand Manager Eugene Smyth said: "We have been in discussion with the regulatory authorities to try and ensure we can meet the demand over the coming months and we have a large team of territory managers and technical services veterinarians dedicated to supporting our customers through the season".

Bovidec BVD virus vaccine, immunises adult cattle against the BVD Type 1 virus and for active immunisation of calves against BVD Type II virus.

Elanco Animal Health has issued a recall for Stresnil 40 mg/ml Solution for injection for Pigs, a sedative used for aggression, stress, obstetric conditions and as an anaesthetic pre-med.

The company has identified that inconsistencies in the cleaning process have led to low levels of a previous product being carried over into the Stresnil batch no PP1466, EXPIRY: 30-09-2019.

For more information about the recall, contact Matthew Edwards: elanco_orders@lilly.com or telephone: 01256 779519.

Scientists from the Institute for Animal Health, Pirbright, UK Met Office and the Jersey State Veterinary Service and Jersey Meteorological Department, are working together on an early-warning system to help defend cattle against the spread of 'bluetongue' disease, according to a study published today in Weather.

The team is fusing meteorological data with ecological information to anticipate when disease carrying midges are likely to be carried on the wind from the continent to the UK and Channel Islands.

Lead author Dr Christopher J. Sanders from the Institute for Animal Health said: "The bluetongue virus, BTV, represents a major and unprecedented epidemic which has spread across Western Europe since 2006. While accurate estimates of costs incurred are not yet available, it is estimated that these could be in the order of many tens of millions of pounds."

BTV is carried by small biting midges, Culicoides, one of the smallest species of biting flies found on livestock. One bite from a midge fully infected with BTV can be enough to lead to infection in cattle and sheep, which can be fatal.

Since 1998 the range of the African species of biting midge has expanded from the Mediterranean basin resulting in an overlap with the range of European species. This enabled European species of midge to pick up virus from infected animals for the first time and go on to transmit it in Southern Europe. However, the arrival of BTV in northern Europe in 2006 was independent of this northwards movement of BTV, jumping north rather than from a gradual spread, and was reliant on transmission only by European midges common and widespread in the area.

In 2006 the disease was found in Belgium, France, the Netherlands, Luxembourg and Germany; 700 km north of previous European outbreaks. In June 2007 the disease was once again reported in Germany and by October 2008 24,000 cases were reported in France alone. In September 2007, the first cases of BTV were discovered in the UK, where fortunately the outbreak was small.

The danger that the disease may again spread to the UK from across the channel is of special concern to the Channel Island of Jersey, which maintains a world renowned cattle industry, but is at heightened risk of infection if the disease becomes established along the Cherbourg peninsula or the Normandy and Brittany coastline.

The risk comes from the possibility that the tiny midges can be carried on the wind from the French coast to the Island. To monitor this threat the team set up midge light traps in farms across the island to monitor midge activity and to identify the presence of any potential vector species.

The results were then collated and analysed alongside data from the Jersey Meteorological Department, which allowed the team to pinpoint when livestock were at risk from a number of locations on the mainland. This information was fed into the UK Met Office early-warning website which has also been used on the mainland to help predict and defend against the disease.

"Environmental conditions, especially temperature, wind speed and direction have a significant impact on the biting midge in terms of activity and abundance," concluded Sanders. "Monitoring the midge population in Jersey will provide the farming community on the mainland with knowledge of when the midge season commences in the diseased areas of the near continent."

Following last week's news from Defra that sales of antibiotics for food-producing animals in the UK have dropped by 27%, comfortably beating the government target of 50mg/kg which was set following the 2016 O’Neill Review on Antimicrobial Resistance, targets for further reducing antibiotic use across the key livestock sectors have been announced by Responsible Use of Medicines in Agriculture (RUMA) Alliance 'Targets Task Force'.

The Targets Task Force comprises a leading veterinary surgeon and farmer from each of the beef, dairy, egg, fish, gamebird, pig, poultry meat and sheep sectors, who have been consulting with key organisations in their respective industries. The group also includes observers from regulators Food Standards Agency and Veterinary Medicines Directorate (VMD).

While the targets each sector has set vary according to the availability of data and scope in their sector, the targets as a whole have been described as 'positive and proactive' by the VMD. 

The headline targets for the eight sectors include a reduction in use of antibiotics in pigs by over 60% between 2015 and 2020, with minimal use of highest priority Critically Important Antibiotics (CIAs). RUMA reports that good progress has already been made in this sector, with usage falling by around 35% between 2015 and 2016.

Targets Task Force member and president of the Pig Veterinary Society Mark White said: "It's encouraging to see the response in the sector to the challenge laid down, which bodes well for achieving our ambitious 2020 goal. It is evident that the sector – steered mainly by the members of the Pig Veterinary Society, AHDB Pork and the National Pig Association – has the will and the capability to fully engage with the issue."

Next steps, he said, were to focus on eliminating routine preventative treatment where it is still happening, mainly due to lack of resource or expertise. "We can also work to improve water delivery systems so that more targeted treatment in the water can be used instead of in-feed medication."

The dairy cattle sector has committed to a 20% reduction by 2020, with a particular focus on halving use of the highest priority CIAs. The work to achieve this will be led by a newly-created Dairy Antimicrobial Stewardship Group (DASG) which includes all key organisations in the sector.

Some of the strategies to achieve these goals in dairy farming include reducing the use of antibiotic dry cow therapy and injectable products, and cutting back on group treatments such as antibiotic footbaths for lameness which remain largely unproven, instead using topical and targeted treatments.

Di Wastenage, dairy farmer from Devon, Task Force member and chair of the DASG, said the sector needed to be ambitious about what it could achieve. “While use is lower than in some sectors, there are clear areas to tackle where use can be habitual, or common disease problems go unchallenged.

"For example, eliminating BVD and Persistently Infected animals from the herd is one of the obvious places to start, as well as talking to your vet to calculate the usage levels you have at the moment. Calf rearing can produce a 'hot spot' of treatment, as can digital dermatitis. Everyone has the potential to use antibiotics more responsibly somewhere."

The gamebird sector, having undergone a comprehensive awareness-raising initiative among game rearers in 2017 to cut back on reducing the need for medicines, aims to reduce use by a quarter this year, with a further 25% reduction between 2018 and 2020. 

Three sectors – poultry meat, laying hen and fish – are either already low users of medicines or have made significant reductions over the past five years. These sectors will be focusing on maintaining use at the minimal level needed to ensure good health and welfare among their livestock, while tackling emerging challenges should they arise.

The poultry meat sector, previously described as a 'pathfinder' for the rest of the farming industry, has already reduced use by 71% between 2012, when its stewardship scheme was introduced, and 2016. 

In doing this, the poultry meat sector has also ceased all preventative treatment and use of the highest priority CIAs. It will now maintain current levels in chickens and look for further reductions in turkeys. This sector will use clinical governance to ensure CIA antibiotics are only prescribed when absolutely needed and with sign off from veterinary specialists and management.

The laying hen and fish sectors have similarly committed to continuing low use, with the laying hen sector eliminating all use of highest priority CIAs in the past two years. The development of a vaccine in the salmon sector several years ago successfully controlled one of its most challenging bacterial diseases, so the focus has turned to the health of the ‘cleaner fish’ used to provide natural control of sea lice.

The trout farming sector, with its greater number of small producers, is concentrating on reducing the need for antibiotics and improving data capture.

The beef and sheep sectors are already low users of antibiotics, but have acknowledged they each need better data, and will also commit to addressing 'hotspots' of use. Both have committed to a 10% reduction in antibiotic use by 2020, subject to securing better data.

For the beef sector, reduction in use centres around calves and youngstock, particularly in the areas of respiratory disease. There is also an emphasis on calves from dairy herds, where mixing animals from different sources can create a peak in disease pressure similar to children going to school for the first time.

In sheep, the focus areas are to reduce routine preventative antibiotic usage against abortion (miscarriage), lameness and neonatal lamb diseases such as watery mouth and joint ill. 

With initiatives proving that routine preventative use is largely avoidable through a combination of vaccination, good hygiene, quality nutrition and careful shepherding, Dr Fiona Lovatt of the Targets Task Force is optimistic about the opportunities to reduce overall use.

"In the sheep sector, we’re not high users of antibiotics. But we want to ensure that any use is totally targeted so we are challenging all inappropriate or routine preventative use.  

"Convincing farmers to change practices is tricky, and none of us want to see an increase in levels of disease, but those who have had the courage to work with their vets to change what they do are now seeing what is possible. The answer is to take a holistic approach and work closely with a keen sheep vet."

Gwyn Jones, chair of both RUMA and the Targets Task Force, said he has been overwhelmed by the positivity of the group and its willingness to be ambitious. "The members have worked very hard and have shown incredible leadership and persistence. They have also provided unprecedented support and inspiration to each other.

"I am delighted they have agreed that the group should continue to meet twice-yearly to review progress and discuss issues."

The full report with all targets for each sector can be downloaded from the RUMA website www.ruma.org.uk.

Boehringer Ingelheim has announced the introduction of a new and improved bottle for its respiratory vaccine, Bovalto Respi Intranasal (IN), which can be used in calves from 10 days of age.

Being an intranasal vaccine, Bovalto Respi IN triggers mucosal immunity in the nasal passages and throat area. It can be delivered from 10 days of age without the need for a booster and provides immunity for 12 weeks, from 10 days after vaccination.

Boehringer says it has also been shown to be effective in the face of MDA (maternally derived antibodies).

The new bottle now has a wider neck, which apparently makes for a better fit with the accompanying Respisafe applicator and nozzle. 

Brand manager Matt Yarnall said: "The Respisafe applicator ensures that vaccination is a comfortable process for both farmer and calf and the improved fit will make the job even easier.

"With an intranasal vaccine, it is important that the vaccine droplets coat the mucosa of the nasal passages, where they can begin to work. If they are too big, then the vaccine can run out of the nose, and if too small then the droplets are carried into the lungs and are wasted. The Respisafe system ensures that the optimum size of droplet is administered to the right place in an efficient and easy way.”

Bovalto Respi Intranasal protects against the two main respiratory viruses – RSV and PI3, and during its development it was tested against current strains, that are associated with causing disease in cattle¹.

Stock of the new bottles will start to enter circulation with vets from mid-July, with an expectation that the existing version will still be in circulation until early in the new year.

Reference

1. Philippe-Reversat et al. (2017) Acta vet. BRNO 86: 325-332

The 2009 edition of the NOAH Compendium Data Sheets for Animal Medicines is now being dispatched, free of charge, to each practice premises.

Meanwhile, the online version of the compendium (www.noahcompendium.co.uk), launched 3 years ago to provide a free and convenient source of information about animal medicines for both prescribers and consumers, has just had its 9 millionth page view. The site gets about 3000 visits a day.

Whilst it is possible to order additional print copies of the compendium, NOAH points out that the online version has the beauty of being updated every week with new products, indications and other data. Plus the site is searchable by active ingredient, species, therapeutic indication or text search.

NOAH chief executive Phil Sketchley said: "We try to make the online Compendium as useful and as quick and easy to use as it can be, and while we have received overwhelmingly positive feedback we are always interested to hear how you think it could work better for you, so we can keep this in mind for any future improvements". 

DEFRA has granted a permit allowing the use of Bultavo 3, Boehringer Ingelheim's new vaccine against bluetongue virus serotype 3 in sheep and cattle. 

The current strain of bluetongue emerged in the Netherlands in 2023 and spread rapidly, infecting over 5,000 livestock farms.

Infection of livestock with this serotype of the virus can result in severe clinical signs and high mortality rates¹, significantly impacting animal health, and farming communities.

Bultavo 3 is an inactivated injectable vaccine indicated for the active immunisation against BTV-3.

Boehringer says that in sheep, Bultavo 3 has been shown to significantly reduce viraemia and prevent mortality and clinical signs associated with BTV-3 infection.

Onset of immunity occurs three weeks after administration of a single 1ml subcutaneous dose in sheep.

In cattle, two 1ml intramuscular doses are required, at a three-week interval.

Findlay MacBean, Head of Livestock, UK and Ireland at Boehringer Ingelheim, said: “It’s great news that we can support farmers and authorities in their fight against bluetongue with our new BTV-3 vaccine, Bultavo 3. 

"As we have seen across Europe, and now in the UK, BTV can spread rapidly and causes considerable stress to farmers because of the significant financial impact on those affected.

The availability of Bultavo 3 means future BTV-3 outbreaks can be suppressed, helping farmers protect not only their herds, but also their livelihoods.” 
 
Oli Maxwell, BVSc BSc(Hons) MVM DipECBHM, RCVS Recognised Specialist in Cattle Health and Production and Clinical Director of Green Counties Vets said: “Farmers are justifiably concerned about BTV-3 and its incursion into the UK again this year.

"Reports from colleagues on the continent regarding the severity of clinical signs, especially in sheep are worrying.

"We have seen a huge increase in clients asking about the disease, progress on a vaccine and what this may mean for animal movements at a critical time of year. 

"The availability of a safe and effective vaccine as a critical tool against a disease that we can’t reasonably prevent with biosecurity measures will be a welcome development for many.”

To manage supply and demand, use of the product will initially be subject to geographical restriction with vaccination permitted in high-risk English counties: Norfolk, Suffolk, Essex, Kent and East Sussex.

Reference:

1. Inge Santman Berends and René Van der Brom, AHDB technical Webinar 7th of February 2024, Bluetongue virus technical webinar - Insights from the Netherlands on the 2023 outbreak - YouTube https://www.youtube.com/watch?v=rsQkBPkJImg 

The British Veterinary Association is urging the government to put welfare at the heart of any decision-making with regards to moving livestock inside and out of the UK.

In its updated position statement, the association emphasises its support of current UK legislation and says it would like to see improved implementation of current laws, in particular when informed by an evidence-based welfare outcomes approach.

The BVA also recommends that any proposals to improve welfare during transport should embrace all forms of transport and include welfare issues before, during and after movement. This, it says, would help ensure that a well-defined set of animal welfare standards are met for the entirety of any journey.

The BVA recommends that animals are slaughtered as close to the point of production as possible and supports the exploration of further opportunities which would assist this. It recognises that transportation of live animals can be unavoidable in some situations – for example, journeys between the Scottish Islands and Highlands – but says that no animal should be exported to a destination with unknown welfare standards, to one using systems currently banned in the UK or to a country where it would be slaughtered without stunning. 

BVA President Simon Doherty said: "Any kind of movement has the potential to impact on an animal’s health and welfare. Ideally, we’d like to see livestock slaughtered close to the point of production, as long as all legislative health and welfare standards can be maintained. However, we recognise the high standards of welfare in the UK and support better implementation of current legislation.

"We have taken care to reiterate that any improvements made to live animal transport should consider welfare issues before, during and after movement so that a more complete approach is taken on this issue.

"We recognise that journey length is not the only influencer of welfare conditions for animals, and transport needs to be looked at as a whole rather than focusing on single factors. The most important thing for Government to do is to consider the evidence base when it weighs up options for making improvements."

Will Balhatchet MRCVS from The George Farm Vets in Malmesbury, Wiltshire, has been named as Virbac's Young Dairy Vet of The Year.

Nominated by a colleague, Will graduated and joined the practice in 2021, having previously worked as a dairy herdsperson.

In his nomination, clients described Will as having an excellent understanding of the practicalities of running a herd, and said he provides realistic and achievable advice.

The judging panel was impressed by Will’s dedication to improving health, welfare, and productivity on dairy farms with his clear advice and workable action plans.

In addition, Will set up an embryo transfer service, bringing a new service to his practice, along with a robot discussion group, all of which have made a significant and positive impact to his dairy farming clients.

Will said: “It was a real privilege to be awarded the Young Dairy Vet of the Year award amongst so many talented and dedicated farm vets in our line of work.

"Above all it is a testimony to the farmers I work with day to day and the proactive attitude they take to improving their systems which has given me so many opportunities to develop my career”.

This year’s runner up was Hana Ward of Torch Vets in Barnstaple, Devon. 

Photo: Will with last year's winner, Tom Warboys.